Mass Device: "Antidote Looks to Leverage AI, Travel E-Commerce Tech to Improve Clinical Trial Enrollment"

Clinical trial artificial intelligence company Antidote is looking to improve access to and enrollment in clinical trials using technology from the e-commerce world, according to a Wired report.

Antidote was recently covered by WIRED, and Mass Device picked up the story as well. 

"Clinical trial artificial intelligence company Antidote is looking to improve access to and enrollment in clinical trials using technology from the e-commerce world, according to a WIRED report."

Read more on MassDevice.com.

By
Lisa Brockway
On
September 23, 2026

© 2026 Antidote Technologies, Inc.